Ebers Tech Inc is a private Canadian company backed by leaders from the financial sector focussed on the development of superior, differentiated cannabinoid products for a multitude of consumer product and therapeutic applications.
A unique approach
Ebers Pharma is a private company seeking to maximise the enormous therapeutic and commercial potential of cannabinoids through its unique approach:
- Establishing a high-value Intellectual Property (IP) position within a commodity product
- Ebers Pharma will leverage the safety and pharmacology of cannabinoids in more effective, differentiated & robustly protected products
- Ebers Pharma will deliver value through two key channels:
- NutraceuticalWellness & alternative medicine
- PharmaceuticalNext generation of future prescribed cannabinoid therapies
Market Opportunity
$11BN
Legal cannabis market in USA expected to total $11BN in 2018
(1) According to Cowen Research
$23BN
Legal cannabis market in USA projected to total $23BN by 2022
(2) According to Arcview market research
$50BN
Us consumer demand estimated at $50BN, largely serviced by black market
33states
Medical cannabis now legal in 33 states
